Pain Clinical Trial
Official title:
Effect of the PainCoach App on Pain and Opiate Use in the First Two Weeks After Total Knee Replacement: Randomised Controlled Trial
Verified date | May 2019 |
Source | Kliniek ViaSana |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Less is known about pain and opiate use at home directly after total knee replacement (TKR).
Regarding side effects, low opiate use is desired. An e-health application, PainCoach app,
was developed to guide patients in pain control and opiate use.
The aim of this study was to investigate the effect of the PainCoach app on pain and opiate
use in TKR patients in the first two weeks at home after surgery. The hypothesis was that the
use of this app would decrease pain and opiate use.
Status | Completed |
Enrollment | 97 |
Est. completion date | June 8, 2017 |
Est. primary completion date | July 6, 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Planned for primary TKR Exclusion Criteria: - No possession of a smartphone or tablet - Contra-indication to any of the pain medication used in the study - No email address - No internet at home - No thorough command of the Dutch language - Suffering from memory disorders - Surgery under general anaesthesia |
Country | Name | City | State |
---|---|---|---|
Netherlands | Kliniek ViaSana | Mill |
Lead Sponsor | Collaborator |
---|---|
Kliniek ViaSana | St. Anna Ziekenhuis, Geldrop, Netherlands |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in pain at rest in the first two weeks at home after TKR | Pain at rest was daily measured with VAS from 0 (no pain) to 100 (worst imaginable pain) | 14 measurement points: daily from day 1 to 14 after surgery | |
Primary | Change in pain during activity in the first two weeks at home after TKR | Measured with VAS from 0 (no pain) to 100 (worst imaginable pain) | 14 measurement points: daily from day 1 to 14 after surgery | |
Primary | Change in pain at night in the first two weeks at home after TKR | Measured with VAS from 0 (no pain) to 100 (worst imaginable pain) | 14 measurement points: daily from day 1 to 14 after surgery | |
Primary | Change in opiate use in the first two weeks at home after TKR | Oxycodon (5 mg per tablet) use was recorded in quantities per 24 hours | 14 measurement points: daily from day 1 to 14 after surgery | |
Secondary | Pain at rest | Measured with VAS from 0 (no pain) to 100 (worst imaginable pain) | 1 month after surgery | |
Secondary | Pain during activity | Measured with VAS from 0 (no pain) to 100 (worst imaginable pain) | 1 month after surgery | |
Secondary | Pain at night | Measured with VAS from 0 (no pain) to 100 (worst imaginable pain) | 1 month after surgery | |
Secondary | Change in other pain medication use in the first two weeks at home after TKR | i.e. NSAID (Diclofenac), acetaminophen and/or Gabapentin were recorded in quantities per 24 hours | 14 measurement points: daily from day 1 to 14 after surgery | |
Secondary | Change in pain acceptance at rest, during activity and at night in the first two weeks at home after TKR | Measured with a happy smiley (acceptable pain) and a sad smiley (unacceptable pain) | 14 measurement points: daily from day 1 to 14, and at 1 month after surgery | |
Secondary | Change in experiences with the executed recommended physiotherapy exercises in the first two weeks at home after TKR | Measured on a 3-item scale; did too much, exactly enough, or could have done more exercises | 14 measurement points: daily from day 1 to 14 after surgery | |
Secondary | Function | Measured with the Knee injury and Osteoarthritis Outcome Score - Physical Function Short-form (KOOS-PS) with a total score from 0 (no difficulty) to 100 (extreme difficulty) | 1 month after surgery | |
Secondary | Function and pain | Measured with the Oxford Knee Score (OKS) with a total score from 0 (most severe symptoms) to 48 (least severe symptoms) | 1 month after surgery | |
Secondary | Quality of life | Measured with the EuroQol-5D 3 level version (EQ-5D-3L) consisting of two scores: EQ Visual Analogue Scale (EQ VAS) score from 0 (worst imaginable health state) to 100 (best imaginable health state), and EQ-5D descriptive system (EQ-5D index). | 1 month after surgery | |
Secondary | PainCoach app's perceived effectiveness | Usability, added value, and likelihood of being recommended to others was recorded on a 5-item scale ranging from totally agree to totally disagree | Day 14 after surgery | |
Secondary | Active PainCoach app use | Measured with recording the actual amount of app use and defining active use as at least 12 times in total | From day 1 to 14 after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05559255 -
Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI
|
N/A | |
Terminated |
NCT04356352 -
Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain
|
Phase 2/Phase 3 | |
Completed |
NCT04748367 -
Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care
|
N/A | |
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04466111 -
Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
|
||
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05868122 -
A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy
|
Phase 3 | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Completed |
NCT03273114 -
Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain
|
N/A | |
Enrolling by invitation |
NCT06087432 -
Is PNF Application Effective on Temporomandibular Dysfunction
|
N/A | |
Completed |
NCT05508594 -
Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001
|
Phase 2/Phase 3 | |
Recruiting |
NCT03646955 -
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
|
N/A | |
Active, not recruiting |
NCT03472300 -
Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
|
||
Completed |
NCT03678168 -
A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries
|
N/A | |
Completed |
NCT03286543 -
Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System
|
N/A | |
Completed |
NCT03931772 -
Online Automated Self-Hypnosis Program
|
N/A | |
Completed |
NCT02913027 -
Can We Improve the Comfort of Pelvic Exams?
|
N/A | |
Terminated |
NCT02181387 -
Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor?
|
Phase 4 | |
Recruiting |
NCT06032559 -
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
|
Phase 3 | |
Active, not recruiting |
NCT03613155 -
Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care
|